Loading…
CIK 0001697013 • 6 13F filings • May 15, 2025 – Aug 14, 2026
Import this data to Google Sheets with:
=jivedata("eversept-partners-lp","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| 89BIO INC | COM | $2.2M | 0.2% | 303,731 SH | |
| AC IMMUNE SA | SHS | $188K | 0.0% | 100,752 SH | |
| ALECTOR INC | COM | $759K | 0.1% | 617,418 SH | |
| ALIGN TECHNOLOGY INC | COM | $7.8M | 0.8% | 49,277 SH | |
| AMARIN CORP PLC | SPONS ADR NEW | $1.5M | 0.2% | 3,399,204 SH | |
| AUTOLUS THERAPEUTICS PLC | SPON ADS | $533K | 0.1% | 343,947 SH | |
| AVANTOR INC | COM | $2.0M | 0.2% | 122,823 SH | |
| BIO-TECHNE CORP | COM | $16.4M | 1.7% | 280,117 SH | |
| BIOCRYST PHARMACEUTICALS INC | COM | $16.3M | 1.7% | 2,172,436 SH | |
| BRUKER CORP | COM | $20.8M | 2.1% | 499,207 SH | |
| CELLDEX THERAPEUTICS INC NEW | COM NEW | $12.6M | 1.3% | 696,499 SH | |
| CENTENE CORP DEL | COM | $20.7M | 2.1% | 340,339 SH | |
| COMMUNITY HEALTH SYS INC NEW | COM | $22.8M | 2.3% | 8,458,020 SH | |
| EHEALTH INC | COM | $596K | 0.1% | 89,220 SH | |
| ELEVANCE HEALTH INC | COM | $6.8M | 0.7% | 15,698 SH | |
| FORTREA HLDGS INC | COMMON STOCK | $2.2M | 0.2% | 293,275 SH | |
| GLAUKOS CORP | COM | $15.6M | 1.6% | 158,957 SH | |
| GLOBUS MED INC | CL A | $14.1M | 1.4% | 192,893 SH | |
| GOSSAMER BIO INC | COM | $4.3M | 0.4% | 3,896,841 SH | |
| GSK PLC | SPONSORED ADR | $101.6M | 10.3% | 2,623,246 SH | |
| HCA HEALTHCARE INC | COM | $52.7M | 5.4% | 152,502 SH | |
| HEALTHEQUITY INC | COM | $31.1M | 3.2% | 351,976 SH | |
| HUMANA INC | COM | $7.4M | 0.8% | 27,970 SH | |
| ICON PLC | SHS | $1.9M | 0.2% | 10,840 SH | |
| INFLARX NV | COM | $1.7M | 0.2% | 1,675,978 SH | |
| INSPIRE MED SYS INC | COM | $29.7M | 3.0% | 186,425 SH | |
| INVESCO QQQ TR | UNIT SER 1 | $69.2M | 7.0% | 147,603 SH | |
| IONIS PHARMACEUTICALS INC | COM | $15.6M | 1.6% | 517,021 SH | |
| ITEOS THERAPEUTICS INC | COM | $1.3M | 0.1% | 220,196 SH | |
| KARYOPHARM THERAPEUTICS INC | COM NEW | $962K | 0.1% | 257,154 SH | |
| LIQUIDIA CORPORATION | COM NEW | $2.2M | 0.2% | 150,480 SH | |
| MANNKIND CORP | COM NEW | $3.5M | 0.4% | 697,710 SH | |
| MARAVAI LIFESCIENCES HLDGS I | COM CL A | $2.1M | 0.2% | 942,454 SH | |
| MERUS N V | COM | $3.0M | 0.3% | 70,329 SH | |
| MOLINA HEALTHCARE INC | COM | $7.8M | 0.8% | 23,735 SH | |
| NATERA INC | COM | $126.4M | 12.8% | 893,721 SH | |
| NEUROCRINE BIOSCIENCES INC | COM | $18.5M | 1.9% | 167,243 SH | |
| NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | $5.8M | 0.6% | 280,951 SH | |
| NOVAVAX INC | COM NEW | $2.3M | 0.2% | 365,523 SH | |
| PROTAGONIST THERAPEUTICS INC | COM | $26.5M | 2.7% | 547,116 SH | |
| PUMA BIOTECHNOLOGY INC | COM | $816K | 0.1% | 275,788 SH | |
| REPLIGEN CORP | COM | $2.3M | 0.2% | 18,452 SH | |
| REVVITY INC | COM | $31.6M | 3.2% | 299,087 SH | |
| SPDR S&P 500 ETF TR | TR UNIT | $43.0M | 4.4% | 76,900 SH | |
| SUTRO BIOPHARMA INC | COM | $1.5M | 0.2% | 2,292,261 SH | |
| SYNDAX PHARMACEUTICALS INC | COM | $51.7M | 5.3% | 4,212,270 SH | |
| TELEFLEX INCORPORATED | COM | $7.8M | 0.8% | 56,630 SH | |
| TEVA PHARMACEUTICAL INDS LTD | SPONSORED ADS | $21.7M | 2.2% | 1,410,765 SH | |
| TRAVERE THERAPEUTICS INC | COM | $14.6M | 1.5% | 816,254 SH | |
| UNITED THERAPEUTICS CORP DEL | COM | $17.7M | 1.8% | 57,489 SH | |
| VAXCYTE INC | COM | $21.0M | 2.1% | 557,070 SH | |
| VERA THERAPEUTICS INC | CL A | $45.6M | 4.6% | 1,898,804 SH | |
| VIRIDIAN THERAPEUTICS INC | COM | $18.6M | 1.9% | 1,377,674 SH | |
| XOMA ROYALTY CORPORATION | COM NEW | $897K | 0.1% | 45,017 SH | |
| ZENAS BIOPHARMA INC | COM | $3.5M | 0.4% | 445,588 SH | |
| ZIMVIE INC | COM | $22.5M | 2.3% | 2,079,380 SH |
| 13F-HR |
| 0001697013-26-000005 |
| $1.93B |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0001697013-25-000008 | $1.09B | View |
| May 15, 2026 | Q1 2026 | 13F-HR | 0001697013-26-000003 | $1.90B | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0001697013-25-000005 | $984.7M | View |